Role of the hinge region of glucocorticoid receptor for HEXIM1-mediated transcriptional repression

Biochemical and Biophysical Research Communications

Volumn 371, Issue 1, 2008, Pages 44-49

  Yoshikawa, Noritada ^a,b   Shimizu, Noriaki ^a   Sano, Motoaki ^c   Ohnuma, Kei ^a,b   Iwata, Satoshi ^a   Hosono, Osamu ^a,b   Fukuda, Keiichi ^c   Morimoto, Chikao ^a,b   Tanaka, Hirotoshi ^a,b  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b University of Tokyo   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Elongation; Glucocorticoid; HEXIM1; Hinge region; Nuclear receptor; P TEFb; RNA; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; GLUCOCORTICOID RECEPTOR; HEXAMETHYLENE BISACETAMIDE INDUCIBLE PROTEIN 1; OXOSTEROID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN DERIVATIVE; TRANSCRIPTION ELONGATION FACTOR;

ARTICLE; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; KETOSTEROIDS; MOLECULAR SEQUENCE DATA; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PPAR GAMMA; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUCOCORTICOID; RNA-BINDING PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 42749086755     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.155     Document Type: Article

References (19)

1. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21 (2000) 55-89
2. Nuclear Receptors Nomenclature Committee, A unified nomenclature system for the nuclear receptor superfamily, Cell 97 (1999) 161-163.
3. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353 (2005) 1711-1723
4. Rosenfeld M.G., Lunyak V.V., and Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20 (2006) 1405-1428
5. Kumar R., and Thompson E.B. Gene regulation by the glucocorticoid receptor: structure:function relationship. J. Steroid Biochem. Mol. Biol. 94 (2005) 383-394
6. Kullmann M., Schneikert J., Moll J., Heck S., Zeiner M., Gehring U., and Cato A.C. RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J. Biol. Chem. 273 (1998) 14620-14625
7. De Martino M.U., Bhattacharyya N., Alesci S., Ichijo T., Chrousos G.P., and Kino T. The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol. Endocrinol. 18 (2004) 820-833
8. Malik S., and Roeder R.G. Dynamic regulation of pol II transcription by the mammalian mediator complex. Trends Biochem. Sci. 30 (2005) 256-263
9. Peterlin B.M., and Price D.H. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23 (2006) 297-305
10. Zhou Q., and Yik J.H. The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol. Mol. Biol. Rev. 70 (2006) 646-659
11. Wittmann B.M., Fujinaga K., Deng H., Ogba N., and Montano M.M. The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene 24 (2005) 5576-5588
12. Shimizu N., Ouchida R., Yoshikawa N., Hisada T., Watanabe H., Okamoto K., Kusuhara M., Handa H., Morimoto C., and Tanaka H. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b. Proc. Natl. Acad. Sci. USA 102 (2005) 8555-8560
13. Montano M.M., Doughman Y.Q., Deng H., Chaplin L., Yang J., Wang N., Zhou Q., Ward N.L., and Watanabe M. Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor. Circ. Res. (2007)
14. Yoshikawa N., Yamamoto K., Shimizu N., Yamada S., Morimoto C., and Tanaka H. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor. Mol. Endocrinol. 19 (2005) 1110-1124
15. Hollenberg S.M., Giguere V., Segui P., and Evans R.M. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49 (1987) 39-46
16. Carrigan A., Walther R.F., Salem H.A., Wu D., Atlas E., Lefebvre Y.A., and Hache R.J. An active nuclear retention signal in the glucocorticoid receptor functions as a strong inducer of transcriptional activation. J. Biol. Chem. 282 (2007) 10963-10971
17. de Kloet E.R., Derijk R.H., and Meijer O.C. Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 168-179
18. Walker B.R. Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 157 (2007) 545-559
19. Buttgereit F., Burmester G.R., and Lipworth B.J. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet 365 (2005) 801-803